SHR-9803

· Jiangsu HengRui Medicine Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SHR-9803, covering 2025-04-02 to 2025-04-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study of SHR-9803 for Injection in Patients With Advanced Solid Tumors [Phase 1, Phase 2]